Related Experiment Video

Updated: Apr 6, 2026

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow
08:58

Efficient Sampling of Genetically Encoded Biosensor Design Space Enabled with a Design of Experiments and Automation Workflow

Published on: October 17, 2025

816

An in silico approach helped to identify the best experimental design, population, and outcome for future randomized

Agathe Bajard1, Sylvie Chabaud1, Catherine Cornu2

  • 1Centre de Lutte Contre le Cancer Léon Bérard, Unité de Biostatistique et d'Evaluation des Thérapeutiques, 28, rue Laënnec, Lyon 69373, France.

Journal of Clinical Epidemiology
|July 19, 2015
PubMed
Abstract

Insights

Comparing randomized clinical trial designs using simulations reveals that crossover designs require fewer patients for 80% power. Different designs offer trade-offs in duration, precision, and patient exposure to active treatments.

Area of Science:

  • Clinical Trial Design
  • Biostatistics
  • In Silico Simulation

Background:

  • Randomized clinical trials (RCTs) are crucial for evaluating treatment efficacy.
  • Selecting optimal RCT designs is complex, balancing statistical power, precision, and patient welfare.
  • In silico simulations offer a powerful tool to compare design performance before real-world implementation.

Purpose of the Study:

  • To compare the statistical power, treatment effect estimation accuracy, and patient exposure to active treatments across various randomized clinical trial (RCT) experimental designs.
  • To provide data-driven insights for selecting the most appropriate RCT design based on study objectives and constraints.

Main Methods:

  • Simulated a virtual patient population for in silico clinical trials.
  • Modeled treatment effects using dose-response relationships for quantitative and qualitative outcomes.
  • Compared the performance of different RCT designs, including crossover, parallel, randomized withdrawal, drop the loser (DL), early escape, and play the winner (PW), through 1000 simulations per design.

Main Results:

  • Crossover designs required the fewest patients (50) for 80% power, followed by parallel/randomized withdrawal (60), DL (65), and early escape/PW (70).
  • Parallel and early escape designs offered shorter trial durations.
  • Crossover designs provided high statistical power and precision.
  • Play the winner (PW) and drop the loser (DL) designs maximized the number of patients receiving active treatment.

Conclusions:

  • The simulation approach aids in identifying optimal experimental designs, patient populations, and outcomes for future RCTs.
  • This methodology is particularly valuable for drug development in rare diseases, theranostic applications, and personalized medicine.
  • In silico comparisons enable informed decisions for more efficient and effective clinical trial planning.
Keywords:
Experimental designModelingRandomized controlled clinical trialSimulationStatistical analysisTherapeutic evaluation

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.4K
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.5K

Related Concept Videos

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
375
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
391
Randomized Experiments01:13

Randomized Experiments

The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.3K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.6K
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
932